Glow Peptides · Research Journal
KPV Certificate of Analysis: How to Verify a Lot
Glow Peptides Research Team · 2026-09-18
For research use only. Not for human or veterinary use, diagnostic use, or in any therapeutic application.
KPV reaches a bench in three different formats, and each format produces its own certificate of analysis with its own unit of measurement. That is why KPV paperwork gets misread so often: a reader holding a blend vial checks a record written for a single-component vial, or reads a per-capsule figure as though it described a whole bottle. This guide sets out what a KPV certificate should show in each format, how to confirm the container in your hand is the one the document describes, and where the record stops being evidence. Every lot cited below opens a published record in the COA directory.
The field-by-field read-through of a certificate belongs to the guide on how to read a certificate of analysis, and the shorter catalog reference on KPV covers the material itself. This page is narrow on purpose: one compound, three formats, and the checks that tie a physical container to a specific document.
Three documents carry KPV, and they are not interchangeable
Most confused KPV verification starts with a document that is genuine, published, and about something adjacent to what the reader is holding. KPV is sold as a single-component vial. It is also one of the four components of the KLOW blend vial. And the same blend is produced in capsule format, a third record with a third unit. Before reading any result, decide which of the three applies to your container: the catalog code on the label settles that faster than the material name does.
| Format | Catalog code | Content figure on the record | Released lot | Record |
|---|---|---|---|---|
| Single-component vial | KP10 | 10 mg total peptide content per vial | 260421HPKP10 | View certificate |
| KLOW blend vial | KL80 | 80 mg total peptide content per vial, across all four components | 260320HPKL80 | View certificate |
| KLOW blend capsules | KL80-C | 3.5 mg total peptide content per capsule | 2605-SXH-KL35-01 | View certificate |
Read the third column twice, because it is the trap. Those three numbers are not three versions of one specification, and no arithmetic converts one into another.
The single-component record is the simplest and the one worth learning first. Lot 260421HPKP10 is published at /coa/a5ca6211-526a-440c-94a7-27a3269cf875 and describes one material in one container: KPV at 10 mg total peptide content per vial. One compound means one identity result and one purity result, each attributable without ambiguity. Attribution is where the blend records start doing real work.
A very short sequence changes what the tests can settle
KPV is unusual among catalog materials in how little of it there is to analyse. The name is the sequence written in the standard single-letter amino acid code: K for lysine, P for proline, V for valine. Three residues, in that order. Much of what makes peptide analysis difficult follows from chain length, and at three residues most of it is simply absent.
Identity by mass is a tighter question on a short chain
Mass spectrometry confirms identity by comparing an observed mass-to-charge value against the mass computed from the sequence. How decisive that comparison is depends on how large a fraction of the total mass one residue represents.
On a three-residue peptide the molecular mass is small, so a residue that is missing, substituted or added shifts the total by a large proportion of the whole. The observed value either lands on the computed value or lands somewhere obviously different. On a chain of forty or more residues the same single-residue error is a small fractional change against a much larger total, and separating the target from a near neighbour becomes a question of instrument resolution and careful interpretation rather than a glance.
So on a KPV certificate the identity result is doing an unusually clean job, and a document omitting it has given up something it could have had cheaply.
Purity has fewer near neighbours to resolve
Reverse-phase HPLC reports the target peak's area against total detected peak area. What limits that measurement is how many species are present that are chemically similar enough to elute close to the target.
A short sequence is assembled in few coupling steps, so there are few opportunities for a deletion sequence to form, and a truncated version of a three-residue chain differs from the target by a third or two thirds of its length rather than by a couple of per cent. Species that different are not hard to separate. A long synthesis accumulates the opposite situation: many steps, many possible deletion and incomplete-coupling products, and impurities whose retention behaviour sits very close to the target's. Why chain length drives the impurity profile is set out in the guide on solid-phase and liquid-phase peptide synthesis.
A purity figure on a short peptide is therefore a less strained measurement than the same figure on a long one. It does not make the method optional.
The detection settings are part of the claim
Here is the direction in which a short sequence makes the paperwork harder. None of lysine, proline or valine carries an aromatic ring. A sequence with no aromatic residue has no absorbance band in the region where peptides containing tryptophan or tyrosine are conveniently detected, so detection relies on the absorbance of the peptide bond itself in the low-ultraviolet region. That region is far less selective, because many non-peptide species absorb there too. A purity percentage is therefore a percentage of what the detector responded to under one set of conditions, and here those conditions are load-bearing.
So the method belongs on the page beside the result. Both methods used on released lots here are named on the certificates: reverse-phase HPLC for purity, mass spectrometry for identity.
Matching a KP10 vial to its own record
The mechanical check is three strings in agreement: the lot on the label, the lot on the certificate, and the lot in a published record you reached without asking anyone. Two out of three agreeing is a discrepancy to resolve, not a rounding error.
The string is structured rather than random, and recognising the structure serves one purpose: telling a lot number from a catalog code, so you notice when you have been handed the latter. The full grammar across the catalog sits in the reference on peptide lot codes and catalog codes.
| Element | 260421HPKP10 | 260320HPKL80 | 2605-SXH-KL35-01 | What it identifies |
|---|---|---|---|---|
| Date element | 260421 | 260320 | 2605 | A six-digit YYMMDD date attached to the run, shortened on some formats |
| Site code | HP | HP | SXH | A short code for the production site. QL, HP, ZJ and SXH all appear across released lots; what they abbreviate is not published, so read them as opaque tokens |
| Code element | KP10 | KL80 | KL35 | An abbreviation for the material with a content figure attached |
| Sequence element | not present | not present | 01 | Distinguishes runs made close together; present on some lots, not others |
The catalog code grammar is a short compound abbreviation followed by the total peptide content in milligrams. KP10 is KPV at 10 mg total peptide content. A -C suffix marks the capsule form of the same material rather than a vial.
One clarification applies everywhere a milligram figure appears in this article. The 10 in KP10 is the total peptide content of the sealed vial as analysed — a specification of what the container holds. It is not a quantity of anything to be used, and it corresponds to no period of time. It is on the certificate for the same reason the lot number is: so the document can be pinned to one physical object.
Do not infer content from a code across formats
The capsule lot above shows why the code is a locator rather than a specification. The KLOW capsule catalog code is KL80-C, which carries the 80 from the vial format, while the capsule record states 3.5 mg total peptide content per capsule and the lot string embeds a different element again. All three strings are well-formed, none is a typo of the others, and the only one that tells you what a capsule contains is the certificate.
So use the code to confirm which document you should be reading, then read the content figure off that document. Inferring content from a code works within a format and breaks across formats.
Name variants cause false alarms, not real ones
KPV appears in listings and in documents as KPV, as K-P-V, and occasionally in three-letter notation as Lys-Pro-Val. Those are the same three residues written three ways, and a lookup returning nothing because of notation is a transcription problem rather than a finding. The per-compound index of published lot records is the faster route when a string is uncertain: it works from the material to its lots rather than from something you may have mistyped.
Verifying KPV inside the KLOW blend vial
This is the case the general guides cover least well, and the one KPV searchers arrive with most often. KPV is one of the four components of the KLOW blend, and it is the single compositional difference between KLOW and the three-component GLOW blend. What is in the vial is itemised in the guide on what is in the KLOW peptide blend.
Lot 260320HPKL80, catalog code KL80, is published at /coa/5aacb884-dc47-4c0e-913c-8f2b5fe3db35. Two statements about that document need to be exact, because both are routinely misread.
The 80 mg is the total across the vial. It is the combined peptide content of all four components in one sealed container. It is not the content of KPV, not the content of any other single component, and not a quantity of anything to be used. A reader who takes the headline figure as a per-component figure has multiplied the material in their head by four.
A blend certificate has to attribute each result to a named component. Four compounds in one vial are not one compound, so a single purity figure for the vial as a whole would not describe anything. Each component registers as its own chromatographic peak, and each peak's area is the purity statement for that component and no other. Identity works the same way: the mass of each named component has to be found, not the mass of one of them. The specification of ≥99.2% is a floor that applies per component rather than to the mixture.
Verifying the KPV in a KLOW vial therefore means finding KPV named on the document and finding results attributed to that name. A blend certificate reporting one unattributed percentage has said nothing about KPV specifically: the number may be excellent and belong entirely to a different component.
One limit follows from the chemistry above. In a single-component analysis a short non-aromatic sequence has the chromatogram to itself. In a four-component analysis the same peak has to be resolved from three others and from the impurity profile of all four. That is an argument for reading blend certificates more carefully, and the reason per-component attribution is the first thing to check rather than the last.
The capsule record is a third document with a third unit
KLOW blend capsule lot 2605-SXH-KL35-01 is published at /coa/7a6639e6-ace8-49a9-a48d-da9e3ee630aa, and it states 3.5 mg total peptide content per capsule. Three things about that figure are worth being precise about.
The unit is one capsule. The 3.5 mg is the total peptide content of a single capsule, combined across components, in the same way 80 mg describes a whole vial. It is not the content of KPV in a capsule, and it is not the content of a bottle.
A bottle holds thirty capsules, and thirty is a count. It is a number of physical objects in a container, the same kind of fact as a vial's fill volume. It is not a number of days, it describes no period of time, and multiplying a count by an interval produces a figure that appears on no document.
The lot is its own lot. A capsule run is a separate production run with its own record, so a capsule lot's certificate is not a vial lot's certificate and neither substitutes for the other. A supplier offering a vial certificate for a capsule order has answered a different question.
What the purity specification actually states
Purity is the figure everyone reads first, and there are two specific ways to read it wrongly.
It is a floor, not a measured value for your lot. The published specification is ≥99.2%, the number every released lot has to clear before release. That is a different kind of statement from a typical value or an average, both of which tolerate lots sitting below the stated figure by definition. When comparing two suppliers, establish which kind of statement each figure is before comparing digits.
The published record is not where a per-lot percentage lives. The public per-lot view establishes the lot, the material, the methods and the laboratory. It is not a printout of every numeric result, so no article can honestly quote a specific lot's purity percentage from it. Anyone quoting a precise per-lot figure without the document in front of them is reciting the specification and calling it a measurement.
What a KPV certificate cannot establish
A per-lot certificate is the strongest routine evidence available for research material, and it remains a bounded claim.
- It describes one batch. The record for 260421HPKP10 says nothing about the next KP10 lot, and a blend lot's record says nothing about a single-component lot of the same material.
- It is time-stamped, and says nothing about what happened afterwards. Storage conditions — temperature, light exposure, whether the container stayed sealed — sit outside what any certificate can speak to.
- On a blend, it describes components, not proportions you can derive. A total content figure plus four named components does not let you compute any single component's content. If a proportion is not stated, it is not on the document.
Red flags on KPV certificates elsewhere
These are the patterns worth refusing, roughly in order of seriousness. Several are specific to this compound and to blends containing it.
- No lot number, or one that is not on your container. Nothing else on the document applies to what you are holding. That is not a technicality; it is the whole question.
- A blend certificate with one unattributed purity figure. Four components need four results, each tied to a named component. An unattributed number could belong to any of them.
- A blend total presented as a per-component figure. The commonest overstatement in blend listings, and it is visible on the document itself.
- A vial certificate offered for a capsule order, or the reverse. Different formats are different runs with different records and different units.
- A content figure inferred from a catalog code rather than read from the record. Across formats the figure embedded in the code does not track the unit on the document.
- No identity result. On a three-residue sequence, mass confirmation is the least ambiguous test available. Omitting it here is a choice, not a limitation.
- A purity figure with no stated method. Not comparable, not reproducible, not challengeable — and on a sequence with no aromatic residue, where detection settings carry more weight than usual, close to meaningless.
- Documentation only on request. Verification that depends on a seller's cooperation is not independent verification, and the dependency bites exactly when you have a question.
A verification sequence for a KPV lot
Most of this can be done before ordering.
- Identify the format from the catalog code. KP10 is a single-component vial, KL80 the blend vial, a -C suffix capsules. That decides which document applies before you read any result.
- Find the named lot, not the product. A product page asserting that certificates exist is not a certificate.
- Open the record without providing an email address. If a form stands between you and the document, verification sits inside the seller's control.
- Compare the lot string character by character. Label against certificate against published record, hyphens included, copied rather than remembered.
- Confirm both result types are present — identity and purity — with the method stated beside the purity figure and the laboratory named.
- On a blend, find KPV by name and confirm the results beside that name are attributed to it rather than to the vial as a whole.
- Read the content figure in the record's own unit. Per vial for a vial, per capsule for a capsule, never converted.
How this works here
Every released lot is analysed by an independent laboratory — Freedom Diagnostics, named on the certificates themselves — using reverse-phase HPLC for purity and mass spectrometry for identity. The published specification is a floor of ≥99.2%, and on blend material it applies per component rather than to the mixture.
The records are published per lot. The COA directory lists them, the QR code on a container opens the record for that container's own lot, and each material page links its own format's documents: the KPV vial page, the KLOW blend vial page and the KLOW capsule page. There is no account and no request in any of those routes, which is deliberate: a record you can open without asking is a record that existed before you asked.
Two limits belong in the same breath as those claims. Analytical results are specific to one lot and to the method that produced them. And a certificate describes material as analysed on a date; it does not extend forward through storage and handling, and no certificate from any supplier can.
Frequently asked questions
What should a KPV certificate of analysis show?
Four fields carry the weight: a lot number matching the container, an identity result confirming the compound by mass spectrometry, a purity result by reverse-phase HPLC with the method stated beside it, and a named laboratory with a report date. On a three-residue sequence the identity result is an unusually clean measurement, because one residue is a large fraction of a small molecular mass, so a document omitting it has given up something it could have had cheaply.
How do I confirm my KPV vial matches its certificate?
Compare three strings: the lot printed on the label, the lot printed on the certificate, and the lot in a published record you reached without asking the seller. All three must be identical, hyphens included. The released single-component lot is 260421HPKP10, catalog code KP10, and its record sits at /coa/a5ca6211-526a-440c-94a7-27a3269cf875. When a lookup fails, the usual cause is a character misread from a small label, so copy the string rather than typing it from memory before concluding anything about the document.
Does a KLOW certificate cover the KPV in the blend?
It should, and the way to check is to look for KPV named on the document with results attributed to that name. Four compounds in one vial are not one compound, so a single purity figure for the vial as a whole describes nothing in particular. Each component registers as its own chromatographic peak, and each peak area is that component's purity statement. Identity is confirmed per component as well. The published floor of ≥99.2% applies per component rather than to the mixture.
What does 80 mg mean on a KLOW vial?
It is the total peptide content of that sealed vial, combined across all four components as analysed. It is not the content of KPV, not the content of any other single component, and not a quantity of anything to be used. A total content figure plus a list of named components does not let you derive any individual component's share; if a proportion is not printed on the record, it is not on the document. The released blend lot is 260320HPKL80, catalog code KL80.
Is a KPV capsule certificate the same as a vial certificate?
No. A capsule run is a separate production run with its own lot and its own record, and the unit of measurement differs. The released KLOW capsule lot is 2605-SXH-KL35-01, catalog code KL80-C, and its record states 3.5 mg total peptide content per capsule, where a vial record states content per vial. A bottle holds thirty capsules, which is a count of physical objects rather than any span of time.